These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18260882)
1. [Pulmonary hypertension and right ventricular failure. Part X. Prostanoids in the treatment of primary pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Ekinci E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(6):70-7. PubMed ID: 18260882 [TBL] [Abstract][Full Text] [Related]
2. [Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Ekinsi E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(7):73-82. PubMed ID: 18260899 [TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension and right ventricular failure. Part XIV. Differentiated therapy of primary (idiopathic) and associated forms of pulmonary arterial hypertension]. Batyraliev TA; Ekinsi E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2008; 48(3):78-84. PubMed ID: 18429760 [TBL] [Abstract][Full Text] [Related]
4. [Pulmonary hypertension and right ventricular failure. Part XIII. Surgical methods of treatment of various forms of pulmonary arterial hypertension]. Batyraliev TA; Ekinci E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(12):67-73. PubMed ID: 18260983 [TBL] [Abstract][Full Text] [Related]
5. [Pulmonary hypertension and right ventricular failure. Part XII. Nitrous oxide and phosphodiesterase inhibitors in the treatment of primary pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Ekinci E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(8):76-86. PubMed ID: 18260920 [TBL] [Abstract][Full Text] [Related]
6. Prostanoids for pulmonary arterial hypertension. Galiè N; Manes A; Branzi A Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. So PP; Davies RA; Chandy G; Stewart D; Beanlands RS; Haddad H; Pugliese C; Mielniczuk LM Am J Cardiol; 2012 May; 109(10):1504-9. PubMed ID: 22385756 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension and right ventricular failure. Part VI. Classification and pathomorphology of primary pulmonary arterial hypertension. Batyraliev LI; Makhmutkhodzhaev SA; Ecinci E; Pataria SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(1):75-81. PubMed ID: 17431965 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500 [TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension and right ventricular failure. Part VII. Epidemiology, risk factors, and pathogenesis of primary (idiopathic) pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Esinci E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(2):44-56. PubMed ID: 17495821 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies. Waxman AB; Zamanian RT Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683 [TBL] [Abstract][Full Text] [Related]
15. [Pulmonary hypertension and right ventricular failure. Part IX. Traditional therapy of primary pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Pataraia SA; Ekinci E; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(4):74-82. PubMed ID: 18260847 [TBL] [Abstract][Full Text] [Related]
16. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension. de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986 [TBL] [Abstract][Full Text] [Related]
18. Inhaled prostanoids in the therapy of pulmonary hypertension. Gessler T; Seeger W; Schmehl T J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827 [TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of prostacyclins in pulmonary arterial hypertension. Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448 [TBL] [Abstract][Full Text] [Related]
20. [Prostanoids in the treatment of pulmonary arterial hypertension]. Başkurt M; Küçükoğlu MS Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]